25 completed, 9 unknown, 5 withdrawn, 4 terminated. 11 Phase 2, 10 Not applicable, 10 Phase 3, 4 Phase 1, 1 Early Phase 1.
Follow SARS (Severe Acute Respiratory Syndrome): new trials by email Literature Review of SARS (Severe Acute Respiratory Syndrome) trials Research Report on SARS (Severe Acute Respiratory Syndrome)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19. Nitric Oxide Gas, The delivery system will be set up anyway without study gas administration - Coronavirus Covid-19 Infection Variant Omicron, SARS (Severe Acute Respiratory Syndrome) | Phase 2 | Withdrawn | Xijing Hospital | 2023-01-16 | 2023-02-08 | |
| Protocol Design for Evaluating the Immunity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19 Marine liquid and fluids, Impregnation, Incubation - Coronavirus Infections, Coronavirus Sars-Associated | Phase 2 | Unknown | Universidade do Porto | 45 | 2021-10-01 | 2022-04-15 |
| Characteristics of Patients With COVID-19 in Meta State, Colombia COVID, SARS-CoV 2 | Withdrawn | Hospital Departamental de Villavicencio | 2021-09-01 | 2023-07-05 | ||
| A Clinical Evaluation of Pine Trees Health Test System Including the Pine Trees Health Reader and COVID-19 Test for Point-of-Care The Pine Trees Health Test System - SARS (Severe Acute Respiratory Syndrome), Covid19 | Completed | Pine Trees, Inc. | 195 | 2021-08-17 | 2021-11-04 | |
| Quercetin In The Treatment Of SARS-COV 2 Quercetin, Placebo - SARS (Severe Acute Respiratory Syndrome) | Early Phase 1 | Completed | Hôpital Universitaire Sahloul | 200 | 2021-06-01 | 2023-07-06 |
| EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19 BEVA+SOC, SOC - Corona Virus Infection, SARS (Severe Acute Respiratory Syndrome) | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 96 | 2021-04-17 | 2022-12-28 |
| Follow-up of Covid-19 Long Term Sequelae Not applicable (observational study) - COVID-19 Pneumonia, COVID-19 Respiratory Infection | Completed | Azienda Ospedaliera Universitaria Integrata Verona | 7599 | 2021-04-16 | 2024-10-28 | |
| Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects Fostamatinib, Placebo - Covid19, SARS (Severe Acute Respiratory Syndrome) | Phase 3 | Completed | Rigel Pharmaceuticals | 280 | 2021-03-25 | 2023-08-18 |
| Sisonke (Together): OPEN LABEL TRIAL COVID-19 To monitor the effectiveness of the single dose Ad26.COV2.S COVID-19 vaccine - SARS (Severe Acute Respiratory Syndrome) | Phase 3 | Completed | Wits Health Consortium (Pty) Ltd | 477102 | 2021-02-17 | 2022-08-01 |
| Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit Proxalutamide, Placebo - Covid19, SARS (Severe Acute Respiratory Syndrome) | Phase 3 | Withdrawn | Applied Biology, Inc. | 2021-02-08 | 2022-03-04 | |
| Proxalutamide Treatment for Hospitalized COVID-19 Patients Proxalutamide, Placebo - Covid19, SARS (Severe Acute Respiratory Syndrome) | Phase 3 | Completed | Applied Biology, Inc. | 645 | 2021-02-01 | 2021-06-24 |
| Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19) Respiratory infections - Influenza, SARS (Severe Acute Respiratory Syndrome) | Terminated | Imperial College London | 8 | 2021-01-25 | 2024-05-17 | |
| Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease) Ion Mobility Spectrometry (IMS) - SARS (Severe Acute Respiratory Syndrome), Covid19 | Completed | B. Braun Melsungen AG | 450 | 2020-12-14 | 2021-05-03 | |
| Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study) SARS-CoV-2 Infection, COVID-19 | Completed | University of Washington | 155 | 2020-12-10 | 2021-12-15 | |
| Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19] Human biological samples - SARS (Severe Acute Respiratory Syndrome), Covid19 | Completed | Institut Pasteur | 1000 | 2020-11-13 | 2023-07-07 | |
| Colloidal Silver, Treatment of COVID-19 Colloidal Silver, Placebo - SARS (Severe Acute Respiratory Syndrome) | Not applicable | Unknown | Hôpital Universitaire Sahloul | 50 | 2020-11-01 | 2021-07-27 |
| A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 Biological: oral polio vaccine, Comparable Placebo, NA-831 - Covid19, SARS (Severe Acute Respiratory Syndrome) | Phase 3 | Unknown | Biomed Industries, Inc. | 3600 | 2020-11-01 | 2020-09-09 |
| Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Hydroxychloroquine, Vitamins and Minerals, Azithromycin - Covid19, SARS (Severe Acute Respiratory Syndrome) | Phase 1 | Withdrawn | International Brain Research Foundation | 2020-11-01 | 2021-12-07 | |
| Anti-Androgen Treatment for COVID-19 Proxalutamide, Standard of Care - COVID-19, SARS-CoV2 | Not applicable | Completed | Applied Biology, Inc. | 268 | 2020-10-21 | 2021-12-10 |
| Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan Ivermectin / Iota-Carrageenan - Covid19, SARS (Severe Acute Respiratory Syndrome) | Phase 1 / Phase 2 | Completed | Maria de los Angeles Peral de Bruno | 300 | 2020-10-15 | 2021-02-23 |
Showing 20 of 44. Sign in to see all of them.
Severe Acute Respiratory Syndrome (44) · COVID-19 (33) · Coronavirus Infections (15) · Respiratory Distress Syndrome (5) · Pneumonia, Viral (3) · RNA Virus Infections (3) · Respiratory Tract Infections (3) · Virus Diseases (3) · Coronaviridae Infections (2) · Cytokine Release Syndrome (2) · Disease (2) · Nidovirales Infections (2) · Respiratory Insufficiency (2) · Respiratory Tract Diseases (2) · Alopecia (1)
Infections (43) · Coronaviridae Infections (42) · Nidovirales Infections (42) · Respiratory Tract Diseases (42) · RNA Virus Infections (41) · Respiratory Tract Infections (41) · Virus Diseases (41) · Lung Diseases (36) · Pneumonia (33) · Pneumonia, Viral (31) · Coronavirus Infections (29) · Pathological Conditions, Signs and Symptoms (8) · Respiration Disorders (6) · Pathologic Processes (5) · Inflammation (2)
Hydroxychloroquine (3) · proxalutamide (3) · Azithromycin (2) · Endothelium-Dependent Relaxing Factors (2) · Ivermectin (2) · Standard of Care (2) · Ascorbic Acid (1) · Calcifediol (1) · Carrageenan (1) · Cold Temperature (1) · Dexamethasone (1) · Drug Combinations (1) · Exercise (1) · Fertilization (1) · Fluid Therapy (1)
Applied Biology, Inc. (3) · Assistance Publique - Hôpitaux de Paris (2) · Hôpital Universitaire Sahloul (2) · Institut Pasteur (2) · Instituto Nacional de Enfermedades Respiratorias (2) · Lahore General Hospital (2) · University of Sao Paulo (2) · University of Washington (2) · Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) (1) · Apsen Farmaceutica S.A. (1) · Azienda Ospedaliera Universitaria Integrata Verona (1) · B. Braun Melsungen AG (1) · Biomed Industries, Inc. (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Hospital Departamental de Villavicencio (1)
United States (9) · Brazil (8) · France (5) · Argentina (3) · Mexico (3) · Spain (3) · United Kingdom (3) · Belgium (2) · Germany (2) · Italy (2) · Pakistan (2) · Sweden (2) · Tunisia (2) · Denmark (1) · French Guiana (1)
Andy Goren, MD (2) · Flavio Cadegiani, MD (2) · Lorenzo Berra, MD (2) · Ahmad Ameri, Prof. (1) · Anders Kjellberg, MD (1) · Boukef Riadh, professor (1) · Boyle Cheng, PhD (1) · Chong Lei, MD, PhD (1) · Christopher Chiu, PhD (1) · Clovis Silva, PhD (1) · Daniel Fonseca, MD (1) · Eduardo LV Costa, PhD (1) · Evelina Tacconelli, Professor (1) · Flavio A Cadegiani, MD (1)
PMID 31668196, PMID 32091533, PMID 32146445, PMID 32171076, PMID 32187459, PMID 32220207, PMID 32220208, PMID 32227758, PMID 32251768, PMID 32493478, PMID 32511534, PMID 33284679, PMID 33287790, PMID 33528568, PMID 33715160, PMID 33783269, PMID 34029377, PMID 34226219, PMID 34350193, PMID 34473343, PMID 35093205, PMID 35305740, PMID 35350097, PMID 35727802, PMID 35767435, PMID 35891471, PMID 36192801, PMID 36216961, PMID 37063238, PMID 37164620, PMID 37510965, PMID 37654668, PMID 37889107, PMID 38773199, PMID 38849605, PMID 39311582, PMID 39393522, PMID 39432177, PMID 39501479, PMID 40234280, PMID 41788496
3UM1AI068614-14S1 (1)